Abstract
Combined arginine depletion, GCN2 kinase inhibition, and senolytic therapy reduces HCC growth.
©2022 American Association for Cancer Research.
MeSH terms
-
Arginine
-
Carcinoma, Hepatocellular* / drug therapy
-
Carcinoma, Hepatocellular* / genetics
-
Eukaryotic Initiation Factor-2
-
Humans
-
Liver Neoplasms* / drug therapy
-
Protein Serine-Threonine Kinases
-
Senotherapeutics
Substances
-
Eukaryotic Initiation Factor-2
-
Senotherapeutics
-
Arginine
-
Protein Serine-Threonine Kinases